SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-19-022653
Filing Date
2019-12-16
Accepted
2019-12-16 17:26:46
Documents
8
Period of Report
2019-12-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8k.htm 8-K 25970
2 EXHIBIT 1.1 ex1_1.htm EX-1.1 219880
3 EXHIBIT 5.1 ex5_1.htm EX-5.1 12487
4 EXHIBIT 99.1 ex99_1.htm EX-99.1 8781
5 EXHIBIT 99.2 ex99_2.htm EX-99.2 9157
6 image00001.jpg GRAPHIC 2769
7 image00002.jpg GRAPHIC 2164
8 image00003.jpg GRAPHIC 3365
  Complete submission text file 0001140361-19-022653.txt   289278
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

IRS No.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38599 | Film No.: 191288139
SIC: 2834 Pharmaceutical Preparations